Article Type
Review
Published
This narrative review presents and examines current evidence regarding the use of inclisiran for the treatment of hyperlipidaemia and its potential role to reduce cardiovascular events.
Review
This narrative review presents and examines current evidence regarding the use of inclisiran for the treatment of hyperlipidaemia and its potential role to reduce cardiovascular events.
Review
This review highlights the historical timeline of the development of siRNA-based drugs, their clinical indications, potential side-effects and future perspectives.
Meeting Report
The Menarini Asia Pacific Advancing Patient care with EdoXaban (APEX) 2023 Expert Meeting convened in Kuala Lumpur, Malaysia, and provided a forum for experts to explore the occurrence of gastrointestinal bleeding linked to non-vitamin K antagonist oral anticoagulants in Asian clinical practice for stroke prevention in atrial fibrillation. This report amalgamates insights from two segments of the meeting.
Original Research
This retrospective multicentre audit aimed to evaluate the achievement of lipid-lowering targets with bempedoic acid in UK patients based on recommendations in the Joint British Societies (JBS) guidelines for the prevention of cardiovascular disease.
Corrigendum
The authors wish to make the following corrections to their article: Magaña Serrano JA, Cigarroa López JA, Chávez Mendoza A, Ivey-Miranda JB, Mendoza Zavala GH, Olmos Domínguez L, Chávez Leal SA, Pombo Bartelt JE, Herrera-Garza EH, Mercado Leal G, Parra Michel R, Aguilera Mora LF, Nuriulu Escobar PL. Corrigendum: Vulnerable period in heart failure: a window of opportunity for the optimization of treatment – a statement by Mexican experts. Drugs Context. 2024;13:2023-8-1. https://doi.org/10.7573/dic.2023-8-1